# OncoCare — AI-Powered Connected Oncology Platform

> Purpose-built oncology EMR, smart chemotherapy daycare management, automated CTCAE v5.0 toxicity triage, and multi-disciplinary tumor board software. Built by Toshiko Health in compliance with ICMR 2023 Ethical Guidelines for Biomedical AI and India's DPDP Act 2023.

---

## 1. Executive Clinical Summary

OncoCare is an enterprise oncology healthcare SaaS bridging cancer patients, medical oncologists, and hospital daycare centers:

- **Flagship Oncology EMR**: Comprehensive cancer staging (TNM 8th ed.), protocol-driven chemotherapy orders, BSA dosage calculators, and adverse drug interaction checking.
- **Smart Patient Intake & Check-In**: Paperless OPD registrations with Ayushman Bharat Digital Mission (ABDM M1-M3) Scan & Share, FHIR oncology profiles, and genomic biomarker capture.
- **Chemotherapy Toxicity Tracker**: Continuous CTCAE v5.0 patient symptom logging, real-time vitals monitoring, and automated emergency escalation for febrile neutropenia (100.4°F alert).
- **Virtual Tumor Board 360**: Collaborative multidisciplinary team (MDT) case presentation workspace with integrated DICOM viewers and molecular genomics panels.
- **Home Chemotherapy Administration**: Protocol governance, cold-chain medication tracking, and oncology-certified nurse bedside administration SOPs.

---

## 2. Machine & AI Agent Integration Points

OncoCare exposes standardized, machine-readable interfaces for AI agents, clinical copilots, and EHR networks:

- **API Catalog (RFC 9727)**: `https://www.oncocare.tech/.well-known/api-catalog`
- **MCP Server Card (SEP-1649)**: `https://www.oncocare.tech/.well-known/mcp/server-card.json`
- **Agent Skills Discovery (v0.2.0)**: `https://www.oncocare.tech/.well-known/agent-skills/index.json`
- **Agent Registration (auth.md)**: `https://www.oncocare.tech/auth.md`
- **OAuth Protected Resource (RFC 9728)**: `https://www.oncocare.tech/.well-known/oauth-protected-resource`
- **OAuth 2.0 Authorization Server**: `https://www.oncocare.tech/.well-known/oauth-authorization-server`
- **OpenID Connect Discovery**: `https://www.oncocare.tech/.well-known/openid-configuration`
- **OpenAPI 3.1 Specification**: `https://www.oncocare.tech/.well-known/openapi.yaml`
- **Curated Agent Guide (llms.txt)**: `https://www.oncocare.tech/llms.txt`

---

## 3. Core Clinical Tools & Endpoints

| Capability | Specification | Path |
| :--- | :--- | :--- |
| **mRECIST 1.1 Calculator** | Solid tumor response evaluation (CR, PR, SD, PD) | `/tools/mrecist-calculator/` |
| **Chemo Toxicity Tracker** | CTCAE v5.0 adverse events & 100.4°F febrile neutropenia alert | `/chemotherapy-tracker/` |
| **Oncology EMR Cockpit** | Daycare chemotherapy management & dosing | `/oncology-emr/` |
| **Virtual Tumor Board** | MDT clinical staging & consensus capture | `/tumor-board-software/` |
| **ABHA Cancer Records** | ABDM M1-M3 consent-backed electronic health records | `/abha-cancer-records/` |
| **Patient Application** | Interactive chemo diary, vitals & symptom logging | `/patient/` |
| **Doctor Cockpit** | Live oncology EMR for practicing clinicians | `/doctor/` |

---

## 4. Clinical Emergency Guidelines

### Febrile Neutropenia Protocol
- **Definition**: A single oral temperature >= 100.4°F (38.0°C) sustained over 1 hour, or >= 101.0°F (38.3°C) in a patient receiving cytotoxic chemotherapy.
- **Action**: Medical emergency. Requires immediate hospitalization, blood cultures, and prompt initiation of empiric broad-spectrum intravenous antibiotics within 60 minutes.
- **Emergency Hotline**: `+91 22 31846644` (24/7 Clinical Support).

---

## 5. Corporate & Regulatory Identity

- **Legal Entity**: Toshiko Health Private Limited
- **Corporate Identity Number (CIN)**: U47721MH2025PTC442215
- **Headquarters**: Flat No. 502, Floor 5, A Wing, Bhakti Park, Wadala, Mumbai 400037, Maharashtra, India
- **Compliance Standards**: ICMR Biomedical AI Guidelines (2023) • DPDP Act 2023 • ABDM M1–M3 • HIPAA Privacy Rule